View Financial HealthAmco India 配当と自社株買い配当金 基準チェック /06Amco India配当金を支払った記録がありません。主要情報n/a配当利回りn/aバイバック利回り総株主利回りn/a将来の配当利回りn/a配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向n/a最近の配当と自社株買いの更新更新なしすべての更新を表示Recent updatesお知らせ • May 21Amco India Limited to Report Q4, 2026 Results on May 30, 2026Amco India Limited announced that they will report Q4, 2026 results at 12:15 PM, Indian Standard Time on May 30, 2026Valuation Update With 7 Day Price Move • Apr 22Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹76.00, the stock trades at a trailing P/E ratio of 50.1x. Average trailing P/E is 22x in the Chemicals industry in India. Total returns to shareholders of 36% over the past three years.New Risk • Mar 20New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.3% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.3% average weekly change). Earnings have declined by 20% per year over the past 5 years. Market cap is less than US$10m (₹286.2m market cap, or US$3.06m). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.6% net profit margin).New Risk • Feb 12New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 23% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 20% per year over the past 5 years. Market cap is less than US$10m (₹316.7m market cap, or US$3.49m). Minor Risks Share price has been volatile over the past 3 months (8.3% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.6% net profit margin).Reported Earnings • Feb 12Third quarter 2026 earnings released: EPS: ₹0.37 (vs ₹1.60 in 3Q 2025)Third quarter 2026 results: EPS: ₹0.37 (down from ₹1.60 in 3Q 2025). Revenue: ₹285.3m (flat on 3Q 2025). Net income: ₹1.51m (down 77% from 3Q 2025). Profit margin: 0.5% (down from 2.3% in 3Q 2025). Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth.お知らせ • Feb 02Amco India Limited to Report Q3, 2026 Results on Feb 10, 2026Amco India Limited announced that they will report Q3, 2026 results at 12:15 PM, Indian Standard Time on Feb 10, 2026Valuation Update With 7 Day Price Move • Jan 29Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹82.00, the stock trades at a trailing P/E ratio of 29.8x. Average trailing P/E is 22x in the Chemicals industry in India. Total returns to shareholders of 33% over the past three years.Reported Earnings • Nov 05Second quarter 2026 earnings released: EPS: ₹0.64 (vs ₹0.98 in 2Q 2025)Second quarter 2026 results: EPS: ₹0.64 (down from ₹0.98 in 2Q 2025). Revenue: ₹343.6m (up 19% from 2Q 2025). Net income: ₹2.64m (down 34% from 2Q 2025). Profit margin: 0.8% (down from 1.4% in 2Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has remained flat whereas the company’s share price has increased by 3% per year.お知らせ • Oct 27Amco India Limited to Report Q2, 2026 Results on Nov 04, 2025Amco India Limited announced that they will report Q2, 2026 results on Nov 04, 2025Valuation Update With 7 Day Price Move • Oct 07Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₹93.53, the stock trades at a trailing P/E ratio of 30.3x. Average trailing P/E is 26x in the Chemicals industry in India. Total returns to shareholders of 14% over the past three years.お知らせ • Sep 03Amco India Limited, Annual General Meeting, Sep 30, 2025Amco India Limited, Annual General Meeting, Sep 30, 2025, at 13:00 Indian Standard Time.Reported Earnings • Aug 15First quarter 2026 earnings released: ₹0.34 loss per share (vs ₹1.13 profit in 1Q 2025)First quarter 2026 results: ₹0.34 loss per share (down from ₹1.13 profit in 1Q 2025). Revenue: ₹263.5m (up 12% from 1Q 2025). Net loss: ₹1.39m (down 130% from profit in 1Q 2025). Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings.お知らせ • Aug 09Amco India Limited to Report Q1, 2026 Results on Aug 14, 2025Amco India Limited announced that they will report Q1, 2026 results on Aug 14, 2025Valuation Update With 7 Day Price Move • Jun 26Investor sentiment improves as stock rises 28%After last week's 28% share price gain to ₹95.57, the stock trades at a trailing P/E ratio of 21x. Average trailing P/E is 29x in the Chemicals industry in India. Total returns to shareholders of 5.1% over the past three years.New Risk • Jun 21New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.1% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.1% average weekly change). Earnings have declined by 4.6% per year over the past 5 years. Market cap is less than US$10m (₹324.2m market cap, or US$3.74m).Reported Earnings • Jun 02Full year 2025 earnings released: EPS: ₹4.56 (vs ₹2.01 in FY 2024)Full year 2025 results: EPS: ₹4.56 (up from ₹2.01 in FY 2024). Revenue: ₹1.07b (up 3.5% from FY 2024). Net income: ₹18.7m (up 127% from FY 2024). Profit margin: 1.7% (up from 0.8% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 44% per year but the company’s share price has increased by 6% per year, which means it is well ahead of earnings.お知らせ • May 22Amco India Limited to Report Q4, 2025 Results on May 30, 2025Amco India Limited announced that they will report Q4, 2025 results on May 30, 2025New Risk • Apr 17New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 10.0% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (10.0% average weekly change). Earnings have declined by 6.3% per year over the past 5 years. Market cap is less than US$10m (₹339.1m market cap, or US$3.96m). Minor Risk Large one-off items impacting financial results.Valuation Update With 7 Day Price Move • Apr 07Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹76.30, the stock trades at a trailing P/E ratio of 17.7x. Average trailing P/E is 24x in the Chemicals industry in India. Total returns to shareholders of 7.5% over the past three years.Reported Earnings • Feb 16Third quarter 2025 earnings released: EPS: ₹1.60 (vs ₹0.009 in 3Q 2024)Third quarter 2025 results: EPS: ₹1.60 (up from ₹0.009 in 3Q 2024). Revenue: ₹289.3m (up 1.6% from 3Q 2024). Net income: ₹6.59m (up ₹6.55m from 3Q 2024). Profit margin: 2.3% (up from 0% in 3Q 2024). Over the last 3 years on average, earnings per share has fallen by 58% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings.お知らせ • Feb 07Amco India Limited to Report Q3, 2025 Results on Feb 14, 2025Amco India Limited announced that they will report Q3, 2025 results on Feb 14, 2025Valuation Update With 7 Day Price Move • Dec 11Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹94.27, the stock trades at a trailing P/E ratio of 34.7x. Average trailing P/E is 33x in the Chemicals industry in India. Total returns to shareholders of 6.8% over the past three years.Reported Earnings • Nov 15Second quarter 2025 earnings released: EPS: ₹0.93 (vs ₹1.28 in 2Q 2024)Second quarter 2025 results: EPS: ₹0.93 (down from ₹1.28 in 2Q 2024). Revenue: ₹291.5m (up 14% from 2Q 2024). Net income: ₹4.03m (down 24% from 2Q 2024). Profit margin: 1.4% (down from 2.1% in 2Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 72 percentage points per year, which is a significant difference in performance.お知らせ • Nov 06Amco India Limited to Report Q2, 2025 Results on Nov 13, 2024Amco India Limited announced that they will report Q2, 2025 results on Nov 13, 2024Valuation Update With 7 Day Price Move • Nov 01Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹97.80, the stock trades at a trailing P/E ratio of 32.4x. Average trailing P/E is 34x in the Chemicals industry in India. Total returns to shareholders of 41% over the past three years.お知らせ • Oct 20Amco India Limited Announces Board AppointmentsAmco India Limited announced change in the designation of Mrs. Vidhu Gupta as Non-Executive Non Independent Director of the company, at the AGM held on September 20, 2024. The company also announced that the appointment of Ms. Prarthana Gupta as an Independent Director of the Company.Valuation Update With 7 Day Price Move • Oct 14Investor sentiment improves as stock rises 22%After last week's 22% share price gain to ₹90.51, the stock trades at a trailing P/E ratio of 30x. Average trailing P/E is 35x in the Chemicals industry in India. Total returns to shareholders of 103% over the past three years.Valuation Update With 7 Day Price Move • Sep 06Investor sentiment improves as stock rises 25%After last week's 25% share price gain to ₹80.26, the stock trades at a trailing P/E ratio of 26.6x. Average trailing P/E is 35x in the Chemicals industry in India. Total returns to shareholders of 85% over the past three years.お知らせ • Aug 30Amco India Limited, Annual General Meeting, Sep 20, 2024Amco India Limited, Annual General Meeting, Sep 20, 2024, at 13:00 Indian Standard Time.Reported Earnings • Aug 14First quarter 2025 earnings released: EPS: ₹1.13 (vs ₹0.12 in 1Q 2024)First quarter 2025 results: EPS: ₹1.13 (up from ₹0.12 in 1Q 2024). Revenue: ₹238.1m (down 19% from 1Q 2024). Net income: ₹4.66m (up ₹4.16m from 1Q 2024). Profit margin: 2.0% (up from 0.2% in 1Q 2024). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings.お知らせ • Aug 08Amco India Limited to Report Q1, 2025 Results on Aug 13, 2024Amco India Limited announced that they will report Q1, 2025 results on Aug 13, 2024お知らせ • Jul 18Amco India Limited Announces Resignation of Mr. Dharam Pal Agarwal as Independent DirectorAmco India Limited announced that the resignation of Mr. Dharam Pal Agarwal as Independent Director of the Company. Mr. Dharam Pal Agarwal has expressed his desire to resign from the post of Independent Director of the Company with effect from 18 July, 2024, due to his other professional commitments. Consequently, he shall also cease to be the Chairman/Member of the various Committees of the Company.お知らせ • May 24Amco India Limited to Report Q4, 2024 Results on May 30, 2024Amco India Limited announced that they will report Q4, 2024 results on May 30, 2024Reported Earnings • Feb 10Third quarter 2024 earnings released: EPS: ₹0.01 (vs ₹0.10 loss in 3Q 2023)Third quarter 2024 results: EPS: ₹0.01 (up from ₹0.10 loss in 3Q 2023). Revenue: ₹287.7m (down 25% from 3Q 2023). Net income: ₹36.0k (up ₹448.0k from 3Q 2023). Profit margin: 0% (up from net loss in 3Q 2023). Over the last 3 years on average, earnings per share has fallen by 31% per year but the company’s share price has increased by 38% per year, which means it is well ahead of earnings.お知らせ • Feb 02Amco India Limited to Report Q3, 2024 Results on Feb 09, 2024Amco India Limited announced that they will report Q3, 2024 results on Feb 09, 2024New Risk • Dec 01New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (₹277.3m market cap, or US$3.33m). Minor Risks Share price has been volatile over the past 3 months (7.3% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.2% net profit margin).お知らせ • Sep 01Amco India Limited, Annual General Meeting, Sep 30, 2023Amco India Limited, Annual General Meeting, Sep 30, 2023, at 13:00 Indian Standard Time.Reported Earnings • Aug 13First quarter 2024 earnings released: EPS: ₹0.12 (vs ₹1.33 in 1Q 2023)First quarter 2024 results: EPS: ₹0.12 (down from ₹1.33 in 1Q 2023). Revenue: ₹298.0m (down 20% from 1Q 2023). Net income: ₹499.0k (down 91% from 1Q 2023). Profit margin: 0.2% (down from 1.5% in 1Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 51% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Aug 05Amco India Limited to Report Q1, 2024 Results on Aug 12, 2023Amco India Limited announced that they will report Q1, 2024 results on Aug 12, 2023Reported Earnings • Jun 04Full year 2023 earnings released: EPS: ₹1.39 (vs ₹9.85 in FY 2022)Full year 2023 results: EPS: ₹1.39 (down from ₹9.85 in FY 2022). Revenue: ₹1.56b (flat on FY 2022). Net income: ₹5.70m (down 86% from FY 2022). Profit margin: 0.4% (down from 2.6% in FY 2022). Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has increased by 52% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • May 23Amco India Limited to Report Q4, 2023 Results on May 30, 2023Amco India Limited announced that they will report Q4, 2023 results on May 30, 2023Valuation Update With 7 Day Price Move • Apr 05Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹60.00, the stock trades at a trailing P/E ratio of 13.7x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 269% over the past three years.Reported Earnings • Feb 01Third quarter 2023 earnings released: ₹0.10 loss per share (vs ₹2.57 profit in 3Q 2022)Third quarter 2023 results: ₹0.10 loss per share (down from ₹2.57 profit in 3Q 2022). Revenue: ₹386.8m (up 2.8% from 3Q 2022). Net loss: ₹412.0k (down 104% from profit in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 42% per year but the company’s share price has increased by 54% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Jan 21Amco India Limited to Report Q3, 2023 Results on Jan 31, 2023Amco India Limited announced that they will report Q3, 2023 results at 3:30 PM, Indian Standard Time on Jan 31, 2023お知らせ • Jan 18Amco India Limited Announces Resignation of Naseem Ahmad as Independent Director, Effective January 22, 2022Amco India Limited announced the resignation of Mr. Naseem Ahmad as Independent Director, effective January 22, 2022.Board Change • Nov 16Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 2 experienced directors. 4 highly experienced directors. 3 independent directors (4 non-independent directors). Additional Non-Executive Independent Director Naseem Ahmad was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.お知らせ • Nov 03Amco India Limited to Report First Half, 2023 Results on Nov 10, 2022Amco India Limited announced that they will report first half, 2023 results on Nov 10, 2022お知らせ • Sep 09Amco India Limited, Annual General Meeting, Sep 30, 2022Amco India Limited, Annual General Meeting, Sep 30, 2022, at 13:00 Indian Standard Time. Agenda: To receive, consider and adopt the financial statement containing the Balance Sheet as at 31st March 2022 and the Profit and Loss Account for the financial year ended on that date along with the Cash Flow statements,Note & Schedules appended thereto together with the Boards' Report and the Auditors' Report thereon; to consider and appoint a director in place of Mr. Rajeev Gupta, who retires by rotation in terms of section 152(6) of the Companies Act, 2013 and being eligible, offers himself for re-appointment; and to consider the appointment of M/s V.V. Kale & Co., Chartered Accountants as Statutory Auditor of the Company.Reported Earnings • Aug 10First quarter 2023 earnings released: EPS: ₹1.33 (vs ₹1.67 in 1Q 2022)First quarter 2023 results: EPS: ₹1.33 (down from ₹1.67 in 1Q 2022). Revenue: ₹376.8m (down 5.3% from 1Q 2022). Net income: ₹5.46m (down 21% from 1Q 2022). Profit margin: 1.4% (down from 1.7% in 1Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has increased by 77% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Aug 02Amco India Limited to Report Q1, 2023 Results on Aug 09, 2022Amco India Limited announced that they will report Q1, 2023 results at 3:30 PM, Indian Standard Time on Aug 09, 2022Valuation Update With 7 Day Price Move • Jun 28Investor sentiment improved over the past weekAfter last week's 19% share price gain to ₹69.95, the stock trades at a trailing P/E ratio of 7.1x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 242% over the past three years.Reported Earnings • Jun 04Full year 2022 earnings released: EPS: ₹9.85 (vs ₹3.58 in FY 2021)Full year 2022 results: EPS: ₹9.85 (up from ₹3.58 in FY 2021). Revenue: ₹1.58b (up 77% from FY 2021). Net income: ₹40.5m (up 175% from FY 2021). Profit margin: 2.6% (up from 1.6% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 57% per year but the company’s share price has only increased by 36% per year, which means it is significantly lagging earnings growth.お知らせ • May 22Amco India Limited to Report Q4, 2022 Final Results on May 30, 2022Amco India Limited announced that they will report Q4, 2022 final results on May 30, 2022Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. 2 independent directors (4 non-independent directors). Independent Non-Executive Director Ankit Aggarwal was the last independent director to join the board, commencing their role in 2015. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.お知らせ • Apr 21Amco India Limited Appoints Naseem Ahmad as an Additional Non-Executive Independent DirectorAmco India Limited announced that the Board of Directors of the Company based on the recommendation of Nomination and Remuneration Committee have appointed Mr. Naseem Ahmad as an additional Non-Executive Independent Director of the Company effective April 20, 2022.Valuation Update With 7 Day Price Move • Feb 21Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to ₹70.45, the stock trades at a trailing P/E ratio of 8.2x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 220% over the past three years.Reported Earnings • Feb 16Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: ₹2.57 (up from ₹1.04 in 3Q 2021). Revenue: ₹379.9m (up 49% from 3Q 2021). Net income: ₹10.5m (up 146% from 3Q 2021). Profit margin: 2.8% (up from 1.7% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 51% per year whereas the company’s share price has increased by 48% per year.お知らせ • Feb 08Amco India Limited to Report Q3, 2022 Results on Feb 14, 2022Amco India Limited announced that they will report Q3, 2022 results on Feb 14, 2022Valuation Update With 7 Day Price Move • Dec 21Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to ₹76.75, the stock trades at a trailing P/E ratio of 10.8x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 194% over the past three years.Valuation Update With 7 Day Price Move • Nov 30Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹75.15, the stock trades at a trailing P/E ratio of 10.6x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 164% over the past three years.Reported Earnings • Nov 03Second quarter 2022 earnings released: EPS ₹3.23 (vs ₹0.94 in 2Q 2021)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2022 results: Revenue: ₹429.5m (up 93% from 2Q 2021). Net income: ₹13.3m (up 245% from 2Q 2021). Profit margin: 3.1% (up from 1.7% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 33% per year whereas the company’s share price has increased by 29% per year.Valuation Update With 7 Day Price Move • Nov 02Investor sentiment improved over the past weekAfter last week's 29% share price gain to ₹56.50, the stock trades at a trailing P/E ratio of 11.8x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 88% over the past three years.Reported Earnings • Aug 18First quarter 2022 earnings released: EPS ₹1.67 (vs ₹0.47 in 1Q 2021)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2022 results: Revenue: ₹397.8m (up 226% from 1Q 2021). Net income: ₹6.87m (up 273% from 1Q 2021). Profit margin: 1.7% (up from 1.5% in 1Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 11% per year whereas the company’s share price has increased by 7% per year.Reported Earnings • Jul 03Full year 2021 earnings released: EPS ₹3.58 (vs ₹2.14 in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: ₹896.6m (up 4.2% from FY 2020). Net income: ₹14.7m (up 67% from FY 2020). Profit margin: 1.6% (up from 1.0% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 2% per year but the company’s share price has increased by 7% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • Jun 14Investor sentiment improved over the past weekAfter last week's 19% share price gain to ₹49.50, the stock trades at a trailing P/E ratio of 32.3x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 79% over the past three years.Valuation Update With 7 Day Price Move • May 28Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹34.50, the stock trades at a trailing P/E ratio of 22.5x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 4.7% over the past three years.Reported Earnings • Feb 13Third quarter 2021 earnings released: EPS ₹1.04 (vs ₹1.01 in 3Q 2020)The company reported a solid third quarter result with improved earnings and revenues, although profit margins were flat. Third quarter 2021 results: Revenue: ₹255.7m (up 11% from 3Q 2020). Net income: ₹4.29m (up 3.9% from 3Q 2020). Profit margin: 1.7% (in line with 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings.Valuation Update With 7 Day Price Move • Feb 05Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹26.75, the stock is trading at a trailing P/E ratio of 18.1x, up from the previous P/E ratio of 15.7x. This compares to an average P/E of 18x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 36%.お知らせ • Feb 05Amco India Limited to Report Q3, 2021 Results on Feb 12, 2021Amco India Limited announced that they will report Q3, 2021 results on Feb 12, 2021お知らせ • Feb 03Amco India Limited Appoints Priyanka Beniwal as Company Secretary & Compliance OfficerAmco India Limited announced that Board of Directors have appointed Ms. Priyanka Beniwal as Company Secretary & Compliance Officer (Key Managerial Personnel) of the Company with effect from 2 February 2021.Is New 90 Day High Low • Jan 31New 90-day low: ₹23.25The company is down 4.0% from its price of ₹24.20 on 02 November 2020. The Indian market is up 18% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 13% over the same period.Reported Earnings • Nov 13Second quarter 2021 earnings released: EPS ₹0.94The company reported a soft second quarter result with weaker earnings and profit margins, although revenues were improved. Second quarter 2021 results: Revenue: ₹222.8m (up 1.9% from 2Q 2020). Net income: ₹3.85m (down 18% from 2Q 2020). Profit margin: 1.7% (down from 2.1% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 31% per year but the company’s share price has only fallen by 7% per year, which means it has not declined as severely as earnings.Valuation Update With 7 Day Price Move • Nov 04Market bids up stock over the past weekAfter last week's 17% share price gain to ₹26.65, the stock is trading at a trailing P/E ratio of 15.7x, up from the previous P/E ratio of 13.4x. This compares to an average P/E of 16x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 24%.お知らせ • Jul 26Amco India Limited to Report Q4, 2020 Results on Jul 31, 2020Amco India Limited announced that they will report Q4, 2020 results on Jul 31, 2020決済の安定と成長配当データの取得安定した配当: 530133の 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。増加する配当: 530133の配当金が増加しているかどうかを判断するにはデータが不十分です。配当利回り対市場Amco India 配当利回り対市場530133 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (530133)n/a市場下位25% (IN)0.3%市場トップ25% (IN)1.5%業界平均 (Chemicals)0.7%アナリスト予想 (530133) (最長3年)n/a注目すべき配当: 530133は最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。高配当: 530133は最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。株主への利益配当収益カバレッジ: 530133の 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。株主配当金キャッシュフローカバレッジ: 530133が配当金を報告していないため、配当金の持続可能性を計算できません。高配当企業の発掘7D1Y7D1Y7D1YIN 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/27 00:26終値2026/05/27 00:00収益2025/12/31年間収益2025/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Amco India Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • May 21Amco India Limited to Report Q4, 2026 Results on May 30, 2026Amco India Limited announced that they will report Q4, 2026 results at 12:15 PM, Indian Standard Time on May 30, 2026
Valuation Update With 7 Day Price Move • Apr 22Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹76.00, the stock trades at a trailing P/E ratio of 50.1x. Average trailing P/E is 22x in the Chemicals industry in India. Total returns to shareholders of 36% over the past three years.
New Risk • Mar 20New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.3% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.3% average weekly change). Earnings have declined by 20% per year over the past 5 years. Market cap is less than US$10m (₹286.2m market cap, or US$3.06m). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.6% net profit margin).
New Risk • Feb 12New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 23% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 20% per year over the past 5 years. Market cap is less than US$10m (₹316.7m market cap, or US$3.49m). Minor Risks Share price has been volatile over the past 3 months (8.3% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.6% net profit margin).
Reported Earnings • Feb 12Third quarter 2026 earnings released: EPS: ₹0.37 (vs ₹1.60 in 3Q 2025)Third quarter 2026 results: EPS: ₹0.37 (down from ₹1.60 in 3Q 2025). Revenue: ₹285.3m (flat on 3Q 2025). Net income: ₹1.51m (down 77% from 3Q 2025). Profit margin: 0.5% (down from 2.3% in 3Q 2025). Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth.
お知らせ • Feb 02Amco India Limited to Report Q3, 2026 Results on Feb 10, 2026Amco India Limited announced that they will report Q3, 2026 results at 12:15 PM, Indian Standard Time on Feb 10, 2026
Valuation Update With 7 Day Price Move • Jan 29Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹82.00, the stock trades at a trailing P/E ratio of 29.8x. Average trailing P/E is 22x in the Chemicals industry in India. Total returns to shareholders of 33% over the past three years.
Reported Earnings • Nov 05Second quarter 2026 earnings released: EPS: ₹0.64 (vs ₹0.98 in 2Q 2025)Second quarter 2026 results: EPS: ₹0.64 (down from ₹0.98 in 2Q 2025). Revenue: ₹343.6m (up 19% from 2Q 2025). Net income: ₹2.64m (down 34% from 2Q 2025). Profit margin: 0.8% (down from 1.4% in 2Q 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has remained flat whereas the company’s share price has increased by 3% per year.
お知らせ • Oct 27Amco India Limited to Report Q2, 2026 Results on Nov 04, 2025Amco India Limited announced that they will report Q2, 2026 results on Nov 04, 2025
Valuation Update With 7 Day Price Move • Oct 07Investor sentiment improves as stock rises 21%After last week's 21% share price gain to ₹93.53, the stock trades at a trailing P/E ratio of 30.3x. Average trailing P/E is 26x in the Chemicals industry in India. Total returns to shareholders of 14% over the past three years.
お知らせ • Sep 03Amco India Limited, Annual General Meeting, Sep 30, 2025Amco India Limited, Annual General Meeting, Sep 30, 2025, at 13:00 Indian Standard Time.
Reported Earnings • Aug 15First quarter 2026 earnings released: ₹0.34 loss per share (vs ₹1.13 profit in 1Q 2025)First quarter 2026 results: ₹0.34 loss per share (down from ₹1.13 profit in 1Q 2025). Revenue: ₹263.5m (up 12% from 1Q 2025). Net loss: ₹1.39m (down 130% from profit in 1Q 2025). Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings.
お知らせ • Aug 09Amco India Limited to Report Q1, 2026 Results on Aug 14, 2025Amco India Limited announced that they will report Q1, 2026 results on Aug 14, 2025
Valuation Update With 7 Day Price Move • Jun 26Investor sentiment improves as stock rises 28%After last week's 28% share price gain to ₹95.57, the stock trades at a trailing P/E ratio of 21x. Average trailing P/E is 29x in the Chemicals industry in India. Total returns to shareholders of 5.1% over the past three years.
New Risk • Jun 21New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.1% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.1% average weekly change). Earnings have declined by 4.6% per year over the past 5 years. Market cap is less than US$10m (₹324.2m market cap, or US$3.74m).
Reported Earnings • Jun 02Full year 2025 earnings released: EPS: ₹4.56 (vs ₹2.01 in FY 2024)Full year 2025 results: EPS: ₹4.56 (up from ₹2.01 in FY 2024). Revenue: ₹1.07b (up 3.5% from FY 2024). Net income: ₹18.7m (up 127% from FY 2024). Profit margin: 1.7% (up from 0.8% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 44% per year but the company’s share price has increased by 6% per year, which means it is well ahead of earnings.
お知らせ • May 22Amco India Limited to Report Q4, 2025 Results on May 30, 2025Amco India Limited announced that they will report Q4, 2025 results on May 30, 2025
New Risk • Apr 17New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 10.0% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (10.0% average weekly change). Earnings have declined by 6.3% per year over the past 5 years. Market cap is less than US$10m (₹339.1m market cap, or US$3.96m). Minor Risk Large one-off items impacting financial results.
Valuation Update With 7 Day Price Move • Apr 07Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹76.30, the stock trades at a trailing P/E ratio of 17.7x. Average trailing P/E is 24x in the Chemicals industry in India. Total returns to shareholders of 7.5% over the past three years.
Reported Earnings • Feb 16Third quarter 2025 earnings released: EPS: ₹1.60 (vs ₹0.009 in 3Q 2024)Third quarter 2025 results: EPS: ₹1.60 (up from ₹0.009 in 3Q 2024). Revenue: ₹289.3m (up 1.6% from 3Q 2024). Net income: ₹6.59m (up ₹6.55m from 3Q 2024). Profit margin: 2.3% (up from 0% in 3Q 2024). Over the last 3 years on average, earnings per share has fallen by 58% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings.
お知らせ • Feb 07Amco India Limited to Report Q3, 2025 Results on Feb 14, 2025Amco India Limited announced that they will report Q3, 2025 results on Feb 14, 2025
Valuation Update With 7 Day Price Move • Dec 11Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹94.27, the stock trades at a trailing P/E ratio of 34.7x. Average trailing P/E is 33x in the Chemicals industry in India. Total returns to shareholders of 6.8% over the past three years.
Reported Earnings • Nov 15Second quarter 2025 earnings released: EPS: ₹0.93 (vs ₹1.28 in 2Q 2024)Second quarter 2025 results: EPS: ₹0.93 (down from ₹1.28 in 2Q 2024). Revenue: ₹291.5m (up 14% from 2Q 2024). Net income: ₹4.03m (down 24% from 2Q 2024). Profit margin: 1.4% (down from 2.1% in 2Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 72 percentage points per year, which is a significant difference in performance.
お知らせ • Nov 06Amco India Limited to Report Q2, 2025 Results on Nov 13, 2024Amco India Limited announced that they will report Q2, 2025 results on Nov 13, 2024
Valuation Update With 7 Day Price Move • Nov 01Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹97.80, the stock trades at a trailing P/E ratio of 32.4x. Average trailing P/E is 34x in the Chemicals industry in India. Total returns to shareholders of 41% over the past three years.
お知らせ • Oct 20Amco India Limited Announces Board AppointmentsAmco India Limited announced change in the designation of Mrs. Vidhu Gupta as Non-Executive Non Independent Director of the company, at the AGM held on September 20, 2024. The company also announced that the appointment of Ms. Prarthana Gupta as an Independent Director of the Company.
Valuation Update With 7 Day Price Move • Oct 14Investor sentiment improves as stock rises 22%After last week's 22% share price gain to ₹90.51, the stock trades at a trailing P/E ratio of 30x. Average trailing P/E is 35x in the Chemicals industry in India. Total returns to shareholders of 103% over the past three years.
Valuation Update With 7 Day Price Move • Sep 06Investor sentiment improves as stock rises 25%After last week's 25% share price gain to ₹80.26, the stock trades at a trailing P/E ratio of 26.6x. Average trailing P/E is 35x in the Chemicals industry in India. Total returns to shareholders of 85% over the past three years.
お知らせ • Aug 30Amco India Limited, Annual General Meeting, Sep 20, 2024Amco India Limited, Annual General Meeting, Sep 20, 2024, at 13:00 Indian Standard Time.
Reported Earnings • Aug 14First quarter 2025 earnings released: EPS: ₹1.13 (vs ₹0.12 in 1Q 2024)First quarter 2025 results: EPS: ₹1.13 (up from ₹0.12 in 1Q 2024). Revenue: ₹238.1m (down 19% from 1Q 2024). Net income: ₹4.66m (up ₹4.16m from 1Q 2024). Profit margin: 2.0% (up from 0.2% in 1Q 2024). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings.
お知らせ • Aug 08Amco India Limited to Report Q1, 2025 Results on Aug 13, 2024Amco India Limited announced that they will report Q1, 2025 results on Aug 13, 2024
お知らせ • Jul 18Amco India Limited Announces Resignation of Mr. Dharam Pal Agarwal as Independent DirectorAmco India Limited announced that the resignation of Mr. Dharam Pal Agarwal as Independent Director of the Company. Mr. Dharam Pal Agarwal has expressed his desire to resign from the post of Independent Director of the Company with effect from 18 July, 2024, due to his other professional commitments. Consequently, he shall also cease to be the Chairman/Member of the various Committees of the Company.
お知らせ • May 24Amco India Limited to Report Q4, 2024 Results on May 30, 2024Amco India Limited announced that they will report Q4, 2024 results on May 30, 2024
Reported Earnings • Feb 10Third quarter 2024 earnings released: EPS: ₹0.01 (vs ₹0.10 loss in 3Q 2023)Third quarter 2024 results: EPS: ₹0.01 (up from ₹0.10 loss in 3Q 2023). Revenue: ₹287.7m (down 25% from 3Q 2023). Net income: ₹36.0k (up ₹448.0k from 3Q 2023). Profit margin: 0% (up from net loss in 3Q 2023). Over the last 3 years on average, earnings per share has fallen by 31% per year but the company’s share price has increased by 38% per year, which means it is well ahead of earnings.
お知らせ • Feb 02Amco India Limited to Report Q3, 2024 Results on Feb 09, 2024Amco India Limited announced that they will report Q3, 2024 results on Feb 09, 2024
New Risk • Dec 01New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (₹277.3m market cap, or US$3.33m). Minor Risks Share price has been volatile over the past 3 months (7.3% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.2% net profit margin).
お知らせ • Sep 01Amco India Limited, Annual General Meeting, Sep 30, 2023Amco India Limited, Annual General Meeting, Sep 30, 2023, at 13:00 Indian Standard Time.
Reported Earnings • Aug 13First quarter 2024 earnings released: EPS: ₹0.12 (vs ₹1.33 in 1Q 2023)First quarter 2024 results: EPS: ₹0.12 (down from ₹1.33 in 1Q 2023). Revenue: ₹298.0m (down 20% from 1Q 2023). Net income: ₹499.0k (down 91% from 1Q 2023). Profit margin: 0.2% (down from 1.5% in 1Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 51% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Aug 05Amco India Limited to Report Q1, 2024 Results on Aug 12, 2023Amco India Limited announced that they will report Q1, 2024 results on Aug 12, 2023
Reported Earnings • Jun 04Full year 2023 earnings released: EPS: ₹1.39 (vs ₹9.85 in FY 2022)Full year 2023 results: EPS: ₹1.39 (down from ₹9.85 in FY 2022). Revenue: ₹1.56b (flat on FY 2022). Net income: ₹5.70m (down 86% from FY 2022). Profit margin: 0.4% (down from 2.6% in FY 2022). Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has increased by 52% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • May 23Amco India Limited to Report Q4, 2023 Results on May 30, 2023Amco India Limited announced that they will report Q4, 2023 results on May 30, 2023
Valuation Update With 7 Day Price Move • Apr 05Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₹60.00, the stock trades at a trailing P/E ratio of 13.7x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 269% over the past three years.
Reported Earnings • Feb 01Third quarter 2023 earnings released: ₹0.10 loss per share (vs ₹2.57 profit in 3Q 2022)Third quarter 2023 results: ₹0.10 loss per share (down from ₹2.57 profit in 3Q 2022). Revenue: ₹386.8m (up 2.8% from 3Q 2022). Net loss: ₹412.0k (down 104% from profit in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 42% per year but the company’s share price has increased by 54% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Jan 21Amco India Limited to Report Q3, 2023 Results on Jan 31, 2023Amco India Limited announced that they will report Q3, 2023 results at 3:30 PM, Indian Standard Time on Jan 31, 2023
お知らせ • Jan 18Amco India Limited Announces Resignation of Naseem Ahmad as Independent Director, Effective January 22, 2022Amco India Limited announced the resignation of Mr. Naseem Ahmad as Independent Director, effective January 22, 2022.
Board Change • Nov 16Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 2 experienced directors. 4 highly experienced directors. 3 independent directors (4 non-independent directors). Additional Non-Executive Independent Director Naseem Ahmad was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
お知らせ • Nov 03Amco India Limited to Report First Half, 2023 Results on Nov 10, 2022Amco India Limited announced that they will report first half, 2023 results on Nov 10, 2022
お知らせ • Sep 09Amco India Limited, Annual General Meeting, Sep 30, 2022Amco India Limited, Annual General Meeting, Sep 30, 2022, at 13:00 Indian Standard Time. Agenda: To receive, consider and adopt the financial statement containing the Balance Sheet as at 31st March 2022 and the Profit and Loss Account for the financial year ended on that date along with the Cash Flow statements,Note & Schedules appended thereto together with the Boards' Report and the Auditors' Report thereon; to consider and appoint a director in place of Mr. Rajeev Gupta, who retires by rotation in terms of section 152(6) of the Companies Act, 2013 and being eligible, offers himself for re-appointment; and to consider the appointment of M/s V.V. Kale & Co., Chartered Accountants as Statutory Auditor of the Company.
Reported Earnings • Aug 10First quarter 2023 earnings released: EPS: ₹1.33 (vs ₹1.67 in 1Q 2022)First quarter 2023 results: EPS: ₹1.33 (down from ₹1.67 in 1Q 2022). Revenue: ₹376.8m (down 5.3% from 1Q 2022). Net income: ₹5.46m (down 21% from 1Q 2022). Profit margin: 1.4% (down from 1.7% in 1Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 59% per year but the company’s share price has increased by 77% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Aug 02Amco India Limited to Report Q1, 2023 Results on Aug 09, 2022Amco India Limited announced that they will report Q1, 2023 results at 3:30 PM, Indian Standard Time on Aug 09, 2022
Valuation Update With 7 Day Price Move • Jun 28Investor sentiment improved over the past weekAfter last week's 19% share price gain to ₹69.95, the stock trades at a trailing P/E ratio of 7.1x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 242% over the past three years.
Reported Earnings • Jun 04Full year 2022 earnings released: EPS: ₹9.85 (vs ₹3.58 in FY 2021)Full year 2022 results: EPS: ₹9.85 (up from ₹3.58 in FY 2021). Revenue: ₹1.58b (up 77% from FY 2021). Net income: ₹40.5m (up 175% from FY 2021). Profit margin: 2.6% (up from 1.6% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 57% per year but the company’s share price has only increased by 36% per year, which means it is significantly lagging earnings growth.
お知らせ • May 22Amco India Limited to Report Q4, 2022 Final Results on May 30, 2022Amco India Limited announced that they will report Q4, 2022 final results on May 30, 2022
Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 3 highly experienced directors. 2 independent directors (4 non-independent directors). Independent Non-Executive Director Ankit Aggarwal was the last independent director to join the board, commencing their role in 2015. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
お知らせ • Apr 21Amco India Limited Appoints Naseem Ahmad as an Additional Non-Executive Independent DirectorAmco India Limited announced that the Board of Directors of the Company based on the recommendation of Nomination and Remuneration Committee have appointed Mr. Naseem Ahmad as an additional Non-Executive Independent Director of the Company effective April 20, 2022.
Valuation Update With 7 Day Price Move • Feb 21Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to ₹70.45, the stock trades at a trailing P/E ratio of 8.2x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 220% over the past three years.
Reported Earnings • Feb 16Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: ₹2.57 (up from ₹1.04 in 3Q 2021). Revenue: ₹379.9m (up 49% from 3Q 2021). Net income: ₹10.5m (up 146% from 3Q 2021). Profit margin: 2.8% (up from 1.7% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 51% per year whereas the company’s share price has increased by 48% per year.
お知らせ • Feb 08Amco India Limited to Report Q3, 2022 Results on Feb 14, 2022Amco India Limited announced that they will report Q3, 2022 results on Feb 14, 2022
Valuation Update With 7 Day Price Move • Dec 21Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to ₹76.75, the stock trades at a trailing P/E ratio of 10.8x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 194% over the past three years.
Valuation Update With 7 Day Price Move • Nov 30Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹75.15, the stock trades at a trailing P/E ratio of 10.6x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 164% over the past three years.
Reported Earnings • Nov 03Second quarter 2022 earnings released: EPS ₹3.23 (vs ₹0.94 in 2Q 2021)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2022 results: Revenue: ₹429.5m (up 93% from 2Q 2021). Net income: ₹13.3m (up 245% from 2Q 2021). Profit margin: 3.1% (up from 1.7% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 33% per year whereas the company’s share price has increased by 29% per year.
Valuation Update With 7 Day Price Move • Nov 02Investor sentiment improved over the past weekAfter last week's 29% share price gain to ₹56.50, the stock trades at a trailing P/E ratio of 11.8x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 88% over the past three years.
Reported Earnings • Aug 18First quarter 2022 earnings released: EPS ₹1.67 (vs ₹0.47 in 1Q 2021)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2022 results: Revenue: ₹397.8m (up 226% from 1Q 2021). Net income: ₹6.87m (up 273% from 1Q 2021). Profit margin: 1.7% (up from 1.5% in 1Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 11% per year whereas the company’s share price has increased by 7% per year.
Reported Earnings • Jul 03Full year 2021 earnings released: EPS ₹3.58 (vs ₹2.14 in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: ₹896.6m (up 4.2% from FY 2020). Net income: ₹14.7m (up 67% from FY 2020). Profit margin: 1.6% (up from 1.0% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 2% per year but the company’s share price has increased by 7% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • Jun 14Investor sentiment improved over the past weekAfter last week's 19% share price gain to ₹49.50, the stock trades at a trailing P/E ratio of 32.3x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 79% over the past three years.
Valuation Update With 7 Day Price Move • May 28Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹34.50, the stock trades at a trailing P/E ratio of 22.5x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 4.7% over the past three years.
Reported Earnings • Feb 13Third quarter 2021 earnings released: EPS ₹1.04 (vs ₹1.01 in 3Q 2020)The company reported a solid third quarter result with improved earnings and revenues, although profit margins were flat. Third quarter 2021 results: Revenue: ₹255.7m (up 11% from 3Q 2020). Net income: ₹4.29m (up 3.9% from 3Q 2020). Profit margin: 1.7% (in line with 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings.
Valuation Update With 7 Day Price Move • Feb 05Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹26.75, the stock is trading at a trailing P/E ratio of 18.1x, up from the previous P/E ratio of 15.7x. This compares to an average P/E of 18x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 36%.
お知らせ • Feb 05Amco India Limited to Report Q3, 2021 Results on Feb 12, 2021Amco India Limited announced that they will report Q3, 2021 results on Feb 12, 2021
お知らせ • Feb 03Amco India Limited Appoints Priyanka Beniwal as Company Secretary & Compliance OfficerAmco India Limited announced that Board of Directors have appointed Ms. Priyanka Beniwal as Company Secretary & Compliance Officer (Key Managerial Personnel) of the Company with effect from 2 February 2021.
Is New 90 Day High Low • Jan 31New 90-day low: ₹23.25The company is down 4.0% from its price of ₹24.20 on 02 November 2020. The Indian market is up 18% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 13% over the same period.
Reported Earnings • Nov 13Second quarter 2021 earnings released: EPS ₹0.94The company reported a soft second quarter result with weaker earnings and profit margins, although revenues were improved. Second quarter 2021 results: Revenue: ₹222.8m (up 1.9% from 2Q 2020). Net income: ₹3.85m (down 18% from 2Q 2020). Profit margin: 1.7% (down from 2.1% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 31% per year but the company’s share price has only fallen by 7% per year, which means it has not declined as severely as earnings.
Valuation Update With 7 Day Price Move • Nov 04Market bids up stock over the past weekAfter last week's 17% share price gain to ₹26.65, the stock is trading at a trailing P/E ratio of 15.7x, up from the previous P/E ratio of 13.4x. This compares to an average P/E of 16x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 24%.
お知らせ • Jul 26Amco India Limited to Report Q4, 2020 Results on Jul 31, 2020Amco India Limited announced that they will report Q4, 2020 results on Jul 31, 2020